Molecular Templates, Inc. Annual report pursuant to Section 13 and 15(d)

Balance Sheet Components

12 Months Ended

Dec. 31, 2020

NOTE 6—BALANCE SHEET COMPONENTS

Accrued liabilities comprise the following (in thousands):

	December 31, 2020		December 31, 2019
Accrued liabilities:
General and administrative	$	1,577	$	4,521
Clinical trial related costs		1,743		1,383
Non-clinical research and manufacturing operations		4,321		5,774
Payroll related		4,908		2,849
Other accrued expenses		26		17
Total Accrued liabilities	$	12,575	$	14,544

Other current liabilities comprise the following (in thousands):

	December 31, 2020		December 31, 2019
Other Current liabilities:
Finance Lease Liability, current portion		1		18
Long Term Debt, Current Portion		—		800
Operating Lease Liability, current portion		2,210		1,683
Total Other Current liabilities	$	2,211	$	2,501